Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies.
about
Brain tumorsImaging biomarkers in primary brain tumours.Present and potential future issues in glioblastoma treatment.Switching on the lights for real-time multimodality tumor neuroimaging: The integrated positron-emission tomography/MR imaging system.Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET.Voxel-based clustered imaging by multiparameter diffusion tensor images for glioma grading.Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies.Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?Advances in neuro-oncology imaging.Nuclear Medicine Imaging in Pediatric Neurology18 F-FDG PET standard uptake values of the normal pons in children: establishing a reference value for diffuse intrinsic pontine glioma.Amino acid PET and MR perfusion imaging in brain tumours.Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients.Assessment of molecular markers demonstrates concordance between samples acquired via stereotactic biopsy and open craniotomy in both anaplastic astrocytomas and glioblastomas.Differentiation between Treatment-Induced Necrosis and Recurrent Tumors in Patients with Metastatic Brain Tumors: Comparison among 11C-Methionine-PET, FDG-PET, MR Permeability Imaging, and MRI-ADC-Preliminary Results.
P2860
Q24605136-7F2792E9-4236-4A39-8B50-8B192397ACABQ30880129-F1C01ABE-C88D-4A6C-8939-ACAFC1F66391Q31043603-657E0D74-78CB-4E80-967E-F2652D29FF7EQ33516753-87CB25B4-119E-4BEE-8D87-D8A6976D8170Q33746805-DDF4FD90-8F27-4B3B-81E8-2E248B61E88CQ34092867-C8B3ABED-B171-4914-8DA2-402C81DA5D69Q34190778-663DC2F3-6324-4F73-8980-FC12D8955F2EQ34348544-588D280C-5700-48FC-997D-1ECD502C083DQ35679377-B7754A62-B104-4532-9926-A4FAA89DA4DEQ36339461-30C5D1D4-6EAF-4C1E-A333-2F55CA51F1A2Q36727588-CE3216E1-0E95-4DE2-B52C-D2AF1E1598DFQ37542423-CDAFF269-5A9A-405B-BFCC-8C417564A54BQ38691946-784C0F7E-FA11-4779-B680-33745520016CQ45944638-66DBE9DE-1F06-4A03-BDB7-23DF058AE615Q48140139-A36E14ED-0E13-4E2A-ABD8-C46BE4E9F545Q48270232-27DB1DF8-5CFB-407B-A7CC-38C34ED7EE0D
P2860
Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Combined use of 18F-fluorodeox ...... d stereotactic brain biopsies.
@ast
Combined use of 18F-fluorodeox ...... d stereotactic brain biopsies.
@en
type
label
Combined use of 18F-fluorodeox ...... d stereotactic brain biopsies.
@ast
Combined use of 18F-fluorodeox ...... d stereotactic brain biopsies.
@en
prefLabel
Combined use of 18F-fluorodeox ...... d stereotactic brain biopsies.
@ast
Combined use of 18F-fluorodeox ...... d stereotactic brain biopsies.
@en
P2093
P1476
Combined use of 18F-fluorodeox ...... d stereotactic brain biopsies.
@en
P2093
Benoit Pirotte
David Wikler
Isabelle Salmon
Jacques Brotchi
Maurice Lipszyc
Nicolas Massager
Philippe David
Serge Goldman
P304
P356
10.3171/JNS.2004.101.3.0476
P577
2004-09-01T00:00:00Z